More Than a CDMO
The End-to-End Support of Your Portfolio
Pre-Clinical
Partner with us for cell line and strain development, manufacturability assessments, cell banking and toxicology material generation. Let us guide your path to IND/IMPD submission.
Clinical Phase I, II
Partner with us to develop your initial clinical process for cGMP drug substance and drug product manufacturing.
Clinical Phase III
Partner with us to optimize, scale and characterize your process to meet anticipated therapeutic demands.
Commercialization
Partner with us for process validation and process performance qualification. Leverage our CMC and regulatory services for your BLA/MAA submission and experience our reliability.
Setting New Standards in Tomorrow’s Medicines
0
Billion USD Invested
in recent years
Spotlight
Press Releases
FUJIFILM Biotechnologies Celebrates the Grand Opening of its Commercial-Scale Cell Culture Manufacturing Site in North Carolina
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
